FORTRESS BIOTECH INC FBIO 9.375 PERP A
PFD · PUBLIC · CUSIP 34960Q208
1
institutional holders
-2 vs Q1 2022
75.0k
shares reported held*
$1.4mreported value*
0 new
0 added
1 reduced
2 sold out
net sold ≈ $3.1m (-169.9k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $18.25.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 1 |
| Q1 2020 | 3 |
| Q2 2020 | 3 |
| Q3 2020 | 3 |
| Q4 2020 | 4 |
| Q1 2021 | 3 |
| Q2 2021 | 3 |
| Q3 2021 | 3 |
| Q4 2021 | 3 |
| Q1 2022 | 3 |
| Q2 2022 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 1 | 1 |
| Q4 2020 | 2 | 1 |
| Q1 2021 | 1 | 2 |
| Q2 2021 | 1 | 1 |
| Q3 2021 | 0 | 2 |
| Q4 2021 | 0 | 2 |
| Q1 2022 | 0 | 2 |
| Q2 2022 | 0 | 3 |
Biggest buyers
| None |
Biggest sellers
| Uniplan Investment Counsel, Inc. | Sold out | -149.3k |
| SHIKIAR ASSET MANAGEMENT INC | Reduced | -20.5k |
| Private Capital Group, LLC | Sold out | -135 |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| SHIKIAR ASSET MANAGEMENT INC 0.53% of their portfolio | 75.0k $1.4m | Reduced -20.5k |